We are live on ! Find out more
APGN

Apexigen, Inc. Common Stock
APGN

Delisted

APGN was delisted on the 22nd of August, 2023.

Back to rankings

38 hedge funds and large institutions have $32.5M invested in Apexigen, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

29% more capital invested

Capital invested by funds: $25.3M → $32.5M (+$7.26M)

23% more funds holding

Funds holding: 31 → 38 (+7)

Holders
38
Holders Change
+7
Holders Change %
+22.58%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
10
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KC
Kepos Capital
New York
+$2.99M
2
KIM
Karpus Investment Management
New York
+$1.2M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.06M
4
LA
Linden Advisors
New York
+$621K
5
Walleye Trading
Walleye Trading
New York
+$162K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$147K
2
MSU
Mizuho Securities USA
New York
-$126K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$115K
4
HI
Harbour Investments
Wisconsin
-$10.1K
5
PC
Periscope Capital
Ontario, Canada
-$1.99K
Name Holding Trade Value Shares
Change 		Change in
Stake
GCL
26
Glazer Capital LLC
New York
$146K +$145K +14,547 New
GCIA
27
Gabelli & Co Investment Advisers
New York
$111K +$111K +11,100 New
DWM
28
Dakota Wealth Management
Florida
$110K +$109K +10,950 New
PCM
29
Pinz Capital Management
New York
$104K +$104K +10,391 New
GF
30
Gabelli Funds
New York
$102K – – –
UBS Group
31
UBS Group
Switzerland
$42K +$25.6K +2,565 +162%
HI
32
Harbour Investments
Wisconsin
$37K -$10.1K -1,017 -21%
BHWM
33
Beaird Harris Wealth Management
Texas
$8K +$7.58K +761 New
TRCT
34
Tower Research Capital (TRC)
New York
$3K +$787 +79 +46%
APC
35
Aspire Private Capital
North Carolina
$2K – – –
CFA
36
Carroll Financial Associates
North Carolina
$2K – – –
Osaic Holdings
37
Osaic Holdings
Arizona
$2K +$1.99K +200 New
MSU
38
Mizuho Securities USA
New York
– -$126K -12,674 Closed
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
– -$115K -11,587 Closed
1
2

APGN Hedge Fund Activity: Q4 2021 in Review

38 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Apexigen, Inc. Common Stock (APGN) for Q4 2021, worth a combined $32.5M — up 29% from $25.3M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new APGN positions and 2 closed out — a net gain of 8 holders — while 10 added to existing stakes and 3 trimmed.

The largest buyer was Kepos Capital, adding an estimated $2.99M. The largest seller was Millennium Management, cutting an estimated $147K.

  • 38 institutional investors held Apexigen, Inc. Common Stock (APGN) as of Q4 2021, up from 31 in Q3 2021.
  • Funds reported $32.5M of Apexigen, Inc. Common Stock stock for Q4 2021, up 29% quarter-over-quarter.
  • 10 funds opened new Apexigen, Inc. Common Stock positions in Q4 2021 and 2 closed out, a net change of +8 holders.
  • The largest Apexigen, Inc. Common Stock buyer in Q4 2021 was Kepos Capital, an estimated $2.99M added.
  • The largest Apexigen, Inc. Common Stock seller in Q4 2021 was Millennium Management, an estimated $147K sold.

Based on aggregated 13F filings for Q4 2021.